Skip to main content
Fig. 11 | BMC Medical Genomics

Fig. 11

From: Expression profile and prognostic values of LSM family in skin cutaneous melanoma

Fig. 11

Spearman’s correlation of LSM2 and LSM4 expression with immunomodulators (TISIDB). A. Spearman correlation between Expression (exp) of LSM2 and Immunoinhibitors across SKCM. Top 4 immunoinhibitors displaying the greatest Spearman’s correlation with LSM2 expression. B Spearman correlation between Expression (exp) of LSM2 and Immunostimulators across SKCM. Top 4 immunostimulators displaying the greatest correlation with LSM2 expression. C Spearman correlation between Expression (exp) of LSM2 and MHC across SKCM. Top 4 MHC molecules displaying the greatest relationship with LSM2 expression. D Spearman correlation between Expression (exp) of LSM4 and Immunoinhibitors across SKCM. Top 4 immunoinhibitors displaying the greatest Spearman’s correlation with LSM4 expression. E Spearman correlation between Expression (exp) of LSM4 and Immunostimulators across SKCM. Top 4 immunostimulators displaying the greatest correlation with LSM4 expression. F Spearman correlation between Expression (exp) of LSM4 and MHC across SKCM. Top 4 MHC molecules displaying the greatest relationship with LSM4 expression

Back to article page